Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
+13.54%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$337B
AUM Growth
+$26B
Cap. Flow
-$5.41B
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.87%
Holding
3,368
New
34
Increased
1,112
Reduced
1,460
Closed
69

Sector Composition

1 Technology 29.22%
2 Financials 12.48%
3 Healthcare 11.48%
4 Consumer Discretionary 11.02%
5 Industrials 8.7%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
OBIO icon
3201
Orchestra BioMed
OBIO
$148M
$118K ﹤0.01%
22,296
+10,290
+86% +$54.2K
SBDS
3202
Solo Brands, Inc.
SBDS
$19.4M
$116K ﹤0.01%
53,679
+23,455
+78% +$50.9K
WKHS icon
3203
Workhorse Group
WKHS
$19.1M
$114K ﹤0.01%
1,947
SKYX icon
3204
SKYX Platforms
SKYX
$128M
$111K ﹤0.01%
84,826
CPSS icon
3205
Consumer Portfolio Services
CPSS
$164M
$110K ﹤0.01%
14,590
BTMD icon
3206
Biote Corp
BTMD
$107M
$108K ﹤0.01%
18,644
VGM icon
3207
Invesco Trust Investment Grade Municipals
VGM
$518M
$107K ﹤0.01%
10,819
BKKT icon
3208
Bakkt Holdings
BKKT
$121M
$104K ﹤0.01%
9,056
TVRD
3209
Tvardi Therapeutics, Inc. Common Stock
TVRD
$285M
$104K ﹤0.01%
3,165
SST icon
3210
System1
SST
$60.1M
$98.6K ﹤0.01%
5,033
LEV
3211
DELISTED
The Lion Electric Company
LEV
$98.3K ﹤0.01%
68,951
NVCT icon
3212
Nuvectis Pharma
NVCT
$166M
$97.4K ﹤0.01%
11,883
VIGL
3213
DELISTED
Vigil Neuroscience
VIGL
$91.5K ﹤0.01%
26,840
AKTS
3214
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
$88.4K ﹤0.01%
149,599
LNZA icon
3215
LanzaTech
LNZA
$43.8M
$88K ﹤0.01%
284
ACRV icon
3216
Acrivon Therapeutics
ACRV
$40.9M
$84.5K ﹤0.01%
11,821
PRTH icon
3217
Priority Technology Holdings
PRTH
$629M
$82.3K ﹤0.01%
25,156
PRLD icon
3218
Prelude Therapeutics
PRLD
$64.5M
$79.6K ﹤0.01%
16,797
DADA
3219
DELISTED
Dada Nexus
DADA
$79.5K ﹤0.01%
38,800
DZSI
3220
DELISTED
DZS Inc. Common Stock
DZSI
$78.9K ﹤0.01%
59,788
GORV icon
3221
Lazydays
GORV
$10.4M
$75.7K ﹤0.01%
626
MKTW icon
3222
MarketWise
MKTW
$49.9M
$74K ﹤0.01%
2,138
OPI
3223
Office Properties Income Trust
OPI
$16.2M
$73.5K ﹤0.01%
36,023
-103,211
-74% -$211K
LNSR icon
3224
LENSAR
LNSR
$145M
$63.4K ﹤0.01%
17,865
ZURA icon
3225
Zura Bio
ZURA
$135M
$60.8K ﹤0.01%
23,657